ARTICLE | Company News
NicOx, Ferrer deal
September 19, 2005 7:00 AM UTC
The companies expanded a 2004 deal to develop and market Nicox's NCX 1022 nitric oxide (NO)-releasing derivative of hydrocortisone and other steroid derivatives to treat dermatological diseases (see B...